Skip to main content
logo
PT Saptausaha Gemilangindah Tbk (SAGE)
Jul 31, 2025 - SAGE was delisted (reason: acquired by SUPN)
8.68
-0.02 (-0.23%)
Inactive · Last trade price on Jul 30, 2025

Blueprint Medicines Revenue

Sage Therapeutics had revenue of 139.11M IDR in the quarter ending June 30, 2025, a decrease of -97.16%. This brings the company's revenue in the last twelve months to 9.43B, down -49.71% year-over-year. In the year 2024, Sage Therapeutics had annual revenue of 16.89B, down -23.08%.

Revenue (ttm)
9.43B IDR
Revenue Growth
-49.71%
P/S Ratio
16.04
Revenue / Employee
26,713,280 IDR
Employees
353
Market Cap
9.32M USD

Revenue Chart

* This company reports financials in IDR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.89B-5.07B-23.08%
Dec 31, 202321.96B-13.65B-38.32%
Dec 31, 202235.61B9.60B36.91%
Dec 31, 202126.01B22.53B647.83%
Dec 31, 20203.48B3.15B949.99%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SAGE News

More News